ReviewCellular and molecular life sciences : CMLS2025
TNF-α in traumatic brain injury: a bidirectional effect in regulating neuroimmune and inflammatory responses.
Review in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Utility of selected neuroinflammatory markers following lethal traumatic brain injury: a combined biofluid and tissue-based assessment of TNF-α, CX3CL1, TNFR1, TNFR2 and CX3CR1 expression.International journal of legal medicine · 2026Article
- The Role of Cytokines in Traumatic Brain Injury.Biomedicines · 2026Review
- TNF-mediated hilar interneuron loss and aberrant granule cell migration are associated with chronic cognitive deficits following TBI.Brain, behavior, and immunity · 2026Article
- Effects of GABAAR modulators CL218872 and MRK-016 on neural repair and synaptic plasticity in mice with Intracerebral hemorrhage.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traumatic brain injury has a high neurological morbidity, it is characterized by structural and physiological damage to brain function caused by external forces. Extensive and sustained damage mediated by neuroimmune and neuroinflammation may be closely associated with the prolonged course of TBI and the worsening of its prognosis. Tumor necrosis factor-alpha, one of the pro-inflammatory mediators, has been identified as a key regulator of the inflammatory response. It has attracted attention for binding to two different receptors, thereby initiating distinct signal transduction pathways. It has been found that there is a lack of relevant summaries of the different factors that make the pro-inflammatory or anti-inflammatory effects of TNF-α in TBI vary significantly. Therefore, this review examines the fundamental signaling pathways that regulate TNF-α in TBI in both the neuroimmune and inflammatory responses. It also reviews the progress of research on the pharmacological and physical technologies that target TNF-α for the treatment of TBI. The review emphasizes the biological effects of TNF-α as a receptor and ligand, as well as current difficulties and challenges.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.